Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 79 Results

Title
Intervention Indication Therapeutic Area Year Actions
Setmelanotide for pro-opiomelanocortin deficiency obesity Setmelanotide (RM-493) Obesity due to pro-opiomelanocortin deficiency Endocrine Nutritional and Metabolic Disorders 2017 View  |  Download
Setmelanotide for rare genetic obesity due to leptin receptor deficiency Setmelanotide (RM-493) Obesity due to Leptin receptor deficiency Endocrine Nutritional and Metabolic Disorders 2019 View  |  Download
Setmelanotide for treating acquired hypothalamic obesity in people 4 years and older Setmelanotide (RM-493) Hypothalamic obesity Endocrine Nutritional and Metabolic Disorders 2024 View  |  Download
Setmelanotide for treating obesity caused by rare genetic disorders in children aged 2 to 6 years Setmelanotide (RM-493) Obesity Endocrine Nutritional and Metabolic Disorders 2022 View  |  Download
Sotagliflozin for type 2 diabetes mellitus Sotagliflozin (Zynquista; SAR439954; LX4211) Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2019 View  |  Download
Sotagliflozin tablets as an adjuct therapy to insulin for Type 1 diabetes mellitus Sotagliflozin (Zynquista; SAR439954; LX4211) Type 1 diabetes Endocrine Nutritional and Metabolic Disorders 2017 View  |  Download
Teplizumab for the delay of clinical type-1 diabetes in at-risk patients aged 8 years and over Teplizumab (PRV-031; MGA031) Type 1 diabetes Endocrine Nutritional and Metabolic Disorders 2022 View  |  Download
Tirzepatide for treating type 2 diabetes mellitus Tirzepatide (LY3298176) Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2021 View  |  Download
Tralesinidase alfa for mucopolysaccharidosis type IIIB (Sanfilippo syndrome type B) Tralesinidase alfa (BMN 250) Mucopolysaccharidosis type IIIB (Sanfilippo B syndrome) Endocrine Nutritional and Metabolic Disorders 2020 View  |  Download
TransCon PTH for treating hypoparathyroidism TransCon PTH Hypoparathyroidism Endocrine Nutritional and Metabolic Disorders 2023 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications